Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.4304
+0.0209 (5.10%)
At close: Aug 10, 2026, 4:00 PM EDT
0.4308
+0.0004 (0.09%)
After-hours: Aug 10, 2026, 7:36 PM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $2.3 million as of August 10, 2026. Its market cap has decreased by -75.82% in one year.
Market Cap
2.30M
Enterprise Value
-7.69M
1-Year Change
-75.82%
Ranking
Category
Stock Price
$0.43
ChartMarket Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $2.30M, a decrease of -96.75%. That is a compound annual growth rate of -28.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.30M | -65.72% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 2.60M |
| Artelo Biosciences | 2.51M |
| Oragenics | 2.48M |
| Clearmind Medicine | 2.42M |
| Virax Biolabs Group | 2.38M |
| Azitra | 2.19M |
| CDT Equity | 2.16M |
| Decoy Therapeutics | 2.09M |